123 related articles for article (PubMed ID: 34656230)
21. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
Phan LM; Fuentes-Mattei E; Wu W; Velazquez-Torres G; Sircar K; Wood CG; Hai T; Jimenez C; Cote GJ; Ozsari L; Hofmann MC; Zheng S; Verhaak R; Pagliaro L; Cortez MA; Lee MH; Yeung SC; Habra MA
Cancer Res; 2015 Oct; 75(19):4131-42. PubMed ID: 26282167
[TBL] [Abstract][Full Text] [Related]
24. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
Ferrucci A; Moschetta M; Frassanito MA; Berardi S; Catacchio I; Ria R; Racanelli V; Caivano A; Solimando AG; Vergara D; Maffia M; Latorre D; Rizzello A; Zito A; Ditonno P; Maiorano E; Ribatti D; Vacca A
Clin Cancer Res; 2014 Nov; 20(22):5796-807. PubMed ID: 25212607
[TBL] [Abstract][Full Text] [Related]
25. A neutralizable epitope is induced on HGF upon its interaction with its receptor cMet.
Kim K; Hur Y; Ryu EK; Rhim JH; Choi CY; Baek CM; Lee JH; Chung J
Biochem Biophys Res Commun; 2007 Mar; 354(1):115-21. PubMed ID: 17214965
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
[TBL] [Abstract][Full Text] [Related]
27. Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.
Venepalli NK; Goff L
Int J Hepatol; 2013; 2013():341636. PubMed ID: 23606971
[TBL] [Abstract][Full Text] [Related]
28. Targeting the hepatocyte growth factor-cMET axis in cancer therapy.
Blumenschein GR; Mills GB; Gonzalez-Angulo AM
J Clin Oncol; 2012 Sep; 30(26):3287-96. PubMed ID: 22869872
[TBL] [Abstract][Full Text] [Related]
29. [Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].
Kang X; Lu P; Cui Y; Wang Y; Zhang Q; Gong Y; Xu Z
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):490-6. PubMed ID: 26463323
[TBL] [Abstract][Full Text] [Related]
30. Investigating the Levels of Soluble Extracellular Domain of HER2 Protein in the Sera of Meningioma Patients.
Abtahi S; Hakimrabet S; Malekzadeh M; Deghanian AR; Ghaderi A
Turk Neurosurg; 2019; 29(1):9-13. PubMed ID: 29384187
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival.
Liang QL; Mo ZY; Wang P; Li X; Liu ZX; Zhou ZM
Med Oncol; 2014 Sep; 31(9):122. PubMed ID: 25064731
[TBL] [Abstract][Full Text] [Related]
32. [Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].
Nishimura M; Ushiyama M; Nanbu A; Ohtsuka K; Yoshimura M
Rinsho Byori; 1998 Jul; 46(7):671-7. PubMed ID: 9721534
[TBL] [Abstract][Full Text] [Related]
33. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.
Cantón A; Burgos R; Hernández C; Mateo C; Segura RM; Mesa J; Simó R
Br J Ophthalmol; 2000 Jul; 84(7):732-5. PubMed ID: 10873984
[TBL] [Abstract][Full Text] [Related]
35. High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma.
Hsiao LT; Lin JT; Yu IT; Chiou TJ; Liu JH; Yen CC; Wang WS; Chen PM
Eur J Haematol; 2003 May; 70(5):282-9. PubMed ID: 12694163
[TBL] [Abstract][Full Text] [Related]
36. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.
Taniguchi T; Kitamura M; Arai K; Iwasaki Y; Yamamoto Y; Igari A; Toi M
Br J Cancer; 1997; 75(5):673-7. PubMed ID: 9043023
[TBL] [Abstract][Full Text] [Related]
37. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
38. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.
Li Q; Weng J; Mohan RR; Bennett GL; Schwall R; Wang ZF; Tabor K; Kim J; Hargrave S; Cuevas KH; Wilson SE
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):727-39. PubMed ID: 8603858
[TBL] [Abstract][Full Text] [Related]
40. Significance of plasma hepatocyte growth factor in diagnosis of benign and malignant solitary pulmonary nodules.
Yu H; Wang Y; Yu Q; Zhang H; Ma W; Shang S; Wang D
Int J Clin Exp Pathol; 2015; 8(2):2063-7. PubMed ID: 25973105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
